Your browser is no longer supported. Please, upgrade your browser.
Settings
ZYNE Zynerba Pharmaceuticals, Inc. daily Stock Chart
ZYNE [NASD]
Zynerba Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.62 Insider Own2.60% Shs Outstand13.90M Perf Week0.96%
Market Cap131.63M Forward P/E- EPS next Y-2.39 Insider Trans2.90% Shs Float10.58M Perf Month52.01%
Income-28.50M PEG- EPS next Q-0.59 Inst Own37.30% Short Float21.05% Perf Quarter-50.29%
Sales0.00M P/S- EPS this Y8.40% Inst Trans-0.75% Short Ratio1.96 Perf Half Y-60.90%
Book/sh5.46 P/B1.73 EPS next Y1.20% ROA-48.10% Target Price12.14 Perf Year-13.04%
Cash/sh5.05 P/C1.88 EPS next 5Y- ROE-54.30% 52W Range5.42 - 25.95 Perf YTD-39.26%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-63.51% Beta-
Dividend %- Quick Ratio9.70 Sales past 5Y- Gross Margin- 52W Low74.72% ATR0.71
Employees12 Current Ratio9.70 Sales Q/Q- Oper. Margin- RSI (14)60.80 Volatility6.66% 8.06%
OptionableYes Debt/Eq0.00 EPS Q/Q9.30% Profit Margin- Rel Volume0.25 Prev Close9.60
ShortableYes LT Debt/Eq0.00 EarningsNov 13 BMO Payout- Avg Volume1.13M Price9.47
Recom2.30 SMA2014.75% SMA5029.81% SMA200-42.25% Volume287,766 Change-1.35%
Oct-02-17Upgrade Cantor Fitzgerald Neutral → Overweight $4 → $17
Sep-29-17Upgrade Piper Jaffray Neutral → Overweight
Aug-15-17Upgrade ROTH Capital Neutral → Buy
Aug-15-17Downgrade Oppenheimer Outperform → Perform
Aug-15-17Downgrade Jefferies Buy → Hold
Aug-08-17Downgrade ROTH Capital Buy → Neutral
Aug-08-17Downgrade H.C. Wainwright Buy → Neutral $7
Aug-07-17Downgrade Piper Jaffray Overweight → Neutral
Aug-07-17Downgrade Maxim Group Buy → Hold
Aug-07-17Downgrade Cantor Fitzgerald Overweight → Neutral $28 → $4
Mar-28-17Reiterated H.C. Wainwright Buy $22 → $30
Feb-24-17Initiated Maxim Group Buy $32
Dec-22-16Initiated Cantor Fitzgerald Overweight $28
Dec-06-16Resumed Jefferies Buy
Oct-07-16Initiated H.C. Wainwright Buy $22
Nov-12-15Reiterated Oppenheimer Outperform $40 → $34
Sep-08-15Initiated Oppenheimer Outperform $40
Aug-31-15Initiated Piper Jaffray Overweight $42
Aug-31-15Initiated Jefferies Buy $33
Oct-16-17 08:21AM  3 Marijuana Stocks That Like to Live Life Dangerously Motley Fool
Oct-04-17 08:39AM  Like a Weed, This Marijuana Stock Catapulted Higher by 34% Last Week Motley Fool
Sep-29-17 04:52PM  Zynerba's Recent Results Revitalize The Bull Case, But Risks Remain Benzinga -11.44%
10:32AM  Zynerba Stock: Where Is It Headed From Here? Investopedia
09:32AM  Microchip Technology, United Continental and Zynerba Pharmaceuticals highlighted as Zacks Bull and Bear of the Day Zacks
09:15AM  Why Zynerba's stock soared 62% this week American City Business Journals
08:10AM  Today's Research Reports on Stocks to Watch: Zynerba Pharmaceuticals and Loxo Oncology ACCESSWIRE
Sep-28-17 04:32PM  Zynerba Pharma (ZYNE) Stock Soars on Positive Cannabis-Based Drug Results Zacks +52.50%
09:25AM  Zynerba Pharma Wins Big on Cannabis Trial 24/7 Wall St.
06:30AM  Zynerba Pharmaceuticals Announces Positive Top Line Results in ZYN002 Open Label Phase 2 FAB-C Study in Children with Fragile X Syndrome GlobeNewswire
Sep-27-17 08:38AM  This Marijuana Stock May Already Be Running Out of Chances to Succeed Motley Fool +5.99%
Sep-18-17 07:30PM  5 Top Marijuana Stocks For 2017 Oilprice.com
Sep-15-17 08:33AM  Of the 14 Largest Marijuana Stocks, Only These 2 Are Down Over the Past Year Motley Fool
Sep-06-17 07:30AM  Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire
Aug-23-17 08:38AM  2 Marijuana Stocks That Have Imploded Since August Began Motley Fool
Aug-18-17 09:18AM  What's The Difference Between Zynerba and GW Pharma's Epilepsy Drugs? Benzinga
Aug-16-17 03:44PM  Zynerba's Pain Could Be GW Pharmaceuticals' Gain Motley Fool
08:38AM  Up in Smoke: This Marijuana Stock Lost More Than Half Its Value Last Week Motley Fool
Aug-14-17 11:49AM  The Zacks Analyst Blog Highlights: Mylan, Perrigo, Esperion's, Zynerba and Valeant Zacks -8.68%
10:10AM  Zynerba Midstage Cannabinoid Trial Falls Short 24/7 Wall St.
09:38AM  Biotech movers: CEL-SCI Leaps After FDA Lets Cancer Study Move Forward TheStreet.com
08:00AM  Zynerba Pharmaceuticals Upcoming Catalysts and Price Targets ACCESSWIRE
06:45AM  Zynerba Pharmaceuticals Announces that Results from Phase 2 STOP Trial Support Continued Development of ZYN002 in Osteoarthritis GlobeNewswire
Aug-11-17 07:05AM  Pharma Stock Roundup: Mylan Misses, Perrigo Tops in Q2, Zynerba Plunges on Study Failure Zacks
Aug-10-17 08:37AM  Are Options Traders Betting on a Big Move in Zynerba Pharmaceuticals (ZYNE) Stock? Zacks
08:00AM  Today's Research Reports on Trending Tickers: Omeros Corporation and Zynerba Pharmaceuticals ACCESSWIRE
Aug-08-17 08:36AM  The Market In 5 Minutes Benzinga -6.00%
07:15AM  Zynerba Pharmas failed cannabidiol gel trial has upside for rival GW Pharma MarketWatch
Aug-07-17 10:34AM  Zynerba shares plunge as cannabis-based epilepsy gel fails study Reuters -55.71%
08:06AM  3 Stocks to Watch on Monday: Alphabet Inc (GOOGL), Zynerba Pharmaceuticals Inc (ZYNE) and Sony Corp (ADR) (SNE) InvestorPlace
08:06AM  Zynerba Pharma shares plummet 53% on failed trial for cannabidiol gel in epilepsy MarketWatch
07:00AM  Zynerba's cannabis-based gel for epilepsy fails study Reuters
06:45AM  Zynerba Pharmaceuticals Announces Top-Line Results from Phase 2 STAR 1 Trial of ZYN002 in Adult Epilepsy Patients with Focal Seizures GlobeNewswire
Aug-03-17 05:09PM  It's High Time For The Cannabis-Related Drug Pipeline Benzinga
Aug-02-17 08:06AM  These 2 Marijuana Stocks Moved in Completely Opposite Directions Last Week Motley Fool -7.30%
Aug-01-17 09:44PM  Zynerba reports 2Q loss Associated Press +6.81%
03:38PM  Cantor Weighs in on Zynerba Pharmaceuticals Inc (ZYNE) as Phase 2 Readouts Approaching SmarterAnalyst
11:59AM  Here's What You Need To Know About Zynerba Pharmaceuticals Benzinga
07:30AM  Zynerba Pharmaceuticals Reports Second Quarter 2017 Financial Results and Operational Highlights GlobeNewswire
Jul-28-17 07:30AM  Zynerba Pharmaceuticals Mourns Passing of Director Cynthia A. Rask GlobeNewswire
Jul-19-17 08:39AM  These 4 Marijuana Stocks All Jumped at Least 10% Last Week Motley Fool
Jul-18-17 08:03AM  Forget GW Pharmaceuticals: These 2 Stocks Are Better Buys Motley Fool
Jul-14-17 08:02AM  5 Things You Need to Know About Marijuana Stock Zynerba Pharmaceuticals Motley Fool
Jul-11-17 01:58PM  Top Biotech Manager Sells Arena Pharmaceuticals On Today's Big Gain Forbes
08:00AM  Today's Research Reports on Trending Tickers: Insys Therapeutics and Zynerba Pharmaceuticals Accesswire
Jul-08-17 08:27AM  Wow! 92% of Patients Prefer Medical Marijuana to Opioids, New Survey Shows Motley Fool
Jul-03-17 08:29AM  4 Marijuana Stocks Looking to Combat the Opioid Epidemic Motley Fool
Jun-26-17 07:45AM  Zynerba Pharmaceuticals Added to the Russell 3000® Index GlobeNewswire
07:30AM  Zynerba Pharmaceuticals Initiates ZYN001 Phase 1 Clinical Program GlobeNewswire
Jun-23-17 04:40PM  Pot Stock Winners of the Week Investopedia
Jun-15-17 11:24AM  Cannabis Is Todd Hagopian's Top Biotech Sub-Sector Forbes
Jun-12-17 04:17PM  Maxim Bullish on Zynerba Pharmaceuticals Inc (ZYNE) Following Meeting with Management SmarterAnalyst -8.74%
Jun-11-17 11:03AM  Marijuana Stock Investors in Awe as California Goes Toe-to-Toe With the Trump Administration Motley Fool
Jun-08-17 07:30AM  Zynerba Pharmaceuticals Achieves Target Enrollment in Exploratory Phase 2 Trial of ZYN002 in Fragile X Syndrome GlobeNewswire
Jun-02-17 01:24PM  Better Know a Marijuana Stock: Zynerba Pharmaceuticals Motley Fool
Jun-01-17 08:16AM  Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-10-17 02:46PM  Zynerba reports 1Q loss Associated Press
May-09-17 07:30AM  Zynerba Pharmaceuticals Reports First Quarter 2017 Financial Results and Operational Highlights GlobeNewswire -6.99%
May-08-17 05:29PM  ETFs with exposure to Zynerba Pharmaceuticals, Inc. : May 8, 2017 Capital Cube
Apr-27-17 04:22PM  ETFs with exposure to Zynerba Pharmaceuticals, Inc. : April 27, 2017 Capital Cube
Apr-17-17 01:13PM  ETFs with exposure to Zynerba Pharmaceuticals, Inc. : April 17, 2017 Capital Cube
08:20AM  Yikes! These 5 Marijuana Stocks Lost a Combined $193 Million in 2016 Motley Fool
Apr-12-17 08:47AM  Implied Volatility Surging for Zynerba Pharmaceuticals (ZYNE) Stock Options Zacks
Apr-05-17 05:49PM  ETFs with exposure to Zynerba Pharmaceuticals, Inc. : April 5, 2017 Capital Cube
Mar-31-17 01:04PM  ZYNERBA PHARMACEUTICALS, INC. Financials
Mar-29-17 10:53AM  Zynerba Pharmaceuticals, Inc. :ZYNE-US: Earnings Analysis: 2016 By the Numbers : March 29, 2017 Capital Cube
Mar-28-17 09:04AM  Edited Transcript of ZYNE earnings conference call or presentation 27-Mar-17 12:30pm GMT Thomson Reuters StreetEvents -5.39%
Mar-27-17 08:30AM  Zynerba Pharmaceuticals Inc Earnings Call scheduled for 8:30 am ET today +7.68%
08:11AM  ZYNERBA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:07AM  Q4 2016 Zynerba Pharmaceuticals Inc Earnings Release - Before Market Open
06:48AM  Zynerba reports 4Q loss Associated Press
06:30AM  Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Operational Highlights GlobeNewswire
Mar-22-17 04:07PM  Cannabis Space Continues To Shine As Latest IPO Therapix BioSciences (TRPX) Oversubscribed Insider Monkey
Mar-17-17 08:15AM  Agile Therapeutics (AGRX) Catches Eye: Stock Moves Up 14% Zacks
Mar-13-17 07:35AM  Zynerba Pharmaceuticals to Report Fourth Quarter and Full-Year 2016 Financial and Operating Results on March 27, 2017 GlobeNewswire
07:30AM  Zynerba Pharmaceuticals Announces Completion of Enrollment for ZYN002 in Two Phase 2 Clinical Trials for Epilepsy and Osteoarthritis GlobeNewswire
07:21AM  ZYNERBA PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Ex
Mar-08-17 04:08PM  Emerging Cannabis Industry Presents Big Opportunities For Investors Benzinga +5.08%
Mar-01-17 07:00AM  Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences GlobeNewswire
Feb-27-17 08:56AM  Cooper (COO) to Report Q1 Earnings: Is a Surprise in Store? +5.36%
Feb-24-17 08:03AM  Coverage initiated on Zynerba Pharma by Maxim Group
Feb-23-17 09:39AM  [2/23] This Weeks Earnings Revisions Movers
09:39AM  Zynerba Pharmaceuticals (ZYNE) Shares March Higher, Can It Continue?
Feb-22-17 08:16AM  Can Penumbra (PEN) Spring a Surprise this Earnings Season?
Feb-21-17 08:46AM  Patterson Companies (PDCO) Q3 Earnings: What's in Store?
Feb-20-17 05:15AM  Medtronic (MDT) Q3 Earnings: Disappointment in the Cards?
Feb-15-17 05:41PM  Harry Boxer: These four momentum stocks are breaking out at MarketWatch
Feb-09-17 07:47AM  ZYNERBA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:35AM  Zynerba Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire
Feb-07-17 10:11AM  Innovative Marijuana-Based Medicines In the Making at Investopedia
Feb-06-17 07:32AM  ZYNERBA PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Jan-26-17 11:32AM  Cannabis Drug Company Zynerba Is Gearing Up For A Big Summer at Forbes
Jan-25-17 02:09PM  Cannabis Stocks Do Not Trade on Earnings, Instead on Pipeline of Drugs
Jan-20-17 11:15AM  Developer of cannabinoid patch seeking $50M from stock sale at bizjournals.com
Jan-19-17 03:27PM  ZYNERBA PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an -19.37%
12:20PM  Thursdays Top Biopharma Movers
09:16AM  Zynerba Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire
09:07AM  GNC Plummets, Mallinckrodt Regains Ground Ahead of Market's Open
Jan-18-17 04:36PM  ZYNERBA PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition +15.18%
04:05PM  Zynerba Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
Zynerba Pharmaceuticals, Inc., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates include ZYN002, which is in Phase II clinical trial for adult patients with refractory epileptic focal seizures and osteoarthritis, as well as pediatric patients with fragile X syndrome; and ZYN001 that is in preclinical stage for the treatment of fibromyalgia and peripheral neuropathic pain. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Devon, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANIDO ARMANDOChairman & Chief Exec. OfficerMay 15Buy19.571,50029,355337,512May 16 08:50 AM
Fickenscher James EChief Financial OfficerMay 12Buy19.825,200103,06412,200May 16 08:50 AM
ANIDO ARMANDOChairman & Chief Exec. OfficerMay 12Buy19.763,50069,160336,012May 16 08:50 AM
RAPP MICHAEL10% OwnerDec 29Buy15.8510,000158,5001,354,115Dec 29 09:54 PM
Fickenscher James EChief Financial OfficerDec 07Buy14.034,00056,1207,000Dec 08 02:01 PM
Fickenscher James EChief Financial OfficerDec 06Buy14.153,00042,4503,000Dec 08 02:01 PM